Related Experiment Video

Updated: Jun 2, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Emerging drugs to treat juvenile idiopathic arthritis

Nicolino Ruperto1, Alberto Martini

  • 1IRCCS Istituto G Gaslini Pediatria II, Reumatologia, Genova, Italy.

Expert Opinion on Emerging Drugs
|May 3, 2011
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a complex condition distinct from adult rheumatoid arthritis (RA). Research is advancing, but new therapies are needed for non-responders, with potential for adult RA drugs in JIA treatment.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Trials

Background:

  • Juvenile idiopathic arthritis (JIA) is a heterogeneous group of childhood-onset arthritic conditions, distinct from adult rheumatoid arthritis (RA).
  • JIA is diagnosed by exclusion, affecting individuals under 16 years with arthritis lasting over six weeks of unknown origin.
  • Classification efforts aim to identify homogeneous subgroups within JIA, though heterogeneity persists in some categories.

Purpose of the Study:

  • To review the current landscape of juvenile idiopathic arthritis (JIA) treatment and research.
  • To highlight advancements in biological therapies and clinical trial methodologies for JIA.
  • To identify unmet needs and future directions in managing JIA, particularly for non-responsive cases.

Main Methods:

  • Review of advancements in biological treatments for JIA.
  • Analysis of the impact of legislation and international research networks on pediatric rheumatology.
  • Exploration of controlled clinical trials and validated outcome measures in JIA research.

Main Results:

  • New biological treatments have significantly altered treatment responses and therapeutic expectations in JIA.
  • Improved legislation and international collaboration have facilitated controlled trials and outcome measure development.
  • Despite progress, challenges remain in treating JIA patients who do not respond adequately to current therapies.

Conclusions:

  • Juvenile idiopathic arthritis (JIA) requires ongoing research to address treatment gaps.
  • Investigational drugs for adult rheumatoid arthritis (RA) show promise for future JIA treatment.
  • Enhanced therapeutic strategies are crucial for improving outcomes in refractory JIA cases.
Abstract

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...